Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001628280-24-050107

Chairman and CEO bought 1,506 shares at an average $1.17 ($1,755)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
KAZIMI A J Chairman and CEO 2024-11-01 Purchase 10b5-1 +76 $1.15 $87 5,700,097 D
KAZIMI A J Chairman and CEO 2024-11-04 Purchase 10b5-1 +49 $1.17 $57 5,700,146 D
KAZIMI A J Chairman and CEO 2024-11-05 Purchase 10b5-1 +76 $1.20 $91 5,700,222 D
KAZIMI A J Chairman and CEO 2024-11-06 Purchase 10b5-1 +76 $1.20 $91 5,700,298 D
KAZIMI A J Chairman and CEO 2024-11-07 Purchase 10b5-1 +76 $1.17 $89 5,700,374 D
KAZIMI A J Chairman and CEO 2024-11-08 Purchase 10b5-1 +76 $1.18 $90 5,700,450 D
KAZIMI A J Chairman and CEO 2024-11-11 Purchase 10b5-1 +76 $1.20 $91 5,700,526 D
KAZIMI A J Chairman and CEO 2024-11-12 Purchase 10b5-1 +76 $1.20 $91 5,700,602 D
KAZIMI A J Chairman and CEO 2024-11-13 Purchase 10b5-1 +76 $1.20 $91 5,700,678 D
KAZIMI A J Chairman and CEO 2024-11-14 Purchase 10b5-1 +76 $1.19 $90 5,700,754 D
KAZIMI A J Chairman and CEO 2024-11-15 Purchase 10b5-1 +76 $1.17 $89 5,700,830 D
KAZIMI A J Chairman and CEO 2024-11-18 Purchase 10b5-1 +76 $1.18 $90 5,700,906 D
KAZIMI A J Chairman and CEO 2024-11-19 Purchase 10b5-1 +76 $1.15 $87 5,700,982 D
KAZIMI A J Chairman and CEO 2024-11-20 Purchase 10b5-1 +85 $1.13 $96 5,701,067 D
KAZIMI A J Chairman and CEO 2024-11-21 Purchase 10b5-1 +85 $1.09 $93 5,701,152 D
KAZIMI A J Chairman and CEO 2024-11-22 Purchase 10b5-1 +75 $1.07 $80 5,701,227 D
KAZIMI A J Chairman and CEO 2024-11-25 Purchase 10b5-1 +75 $1.09 $82 5,701,302 D
KAZIMI A J Chairman and CEO 2024-11-26 Purchase 10b5-1 +75 $1.11 $83 5,701,377 D
KAZIMI A J Chairman and CEO 2024-11-27 Purchase 10b5-1 +75 $1.15 $86 5,701,452 D
KAZIMI A J Chairman and CEO 2024-11-29 Purchase 10b5-1 +75 $1.32 $99 5,701,527 D
Open-market purchases · 1,506 sh · avg $1.17 · $1,755
Loading xslF345X05/wk-form4_1733436201.xml…